Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15259032rdf:typepubmed:Citationlld:pubmed
pubmed-article:15259032lifeskim:mentionsumls-concept:C0035924lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0232910lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0233820lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:15259032lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:15259032pubmed:issue7lld:pubmed
pubmed-article:15259032pubmed:dateCreated2004-7-19lld:pubmed
pubmed-article:15259032pubmed:abstractTextBACKGROUND: In utero rubella virus (RV) infection of a fetus can result in birth defects that are often collectively referred to as congenital rubella syndrome (CRS). In extreme cases, fetal death can occur. In spite of the availability of a safe and effective vaccine against rubella, recent worldwide estimates are that more than 100,000 infants are born with CRS annually. RECENT PROGRESS: Recently, several significant findings in the field of cell biology, as well as in the RV replication and virus-cell interactions, have originated from the authors' laboratory, and other researchers have provided insights into RV teratogenesis. It has been shown that 1) an RV protein induces cell-cycle arrest by generating a subpopulation of tetraploid nuclei (i.e., 4N DNA) cells, perhaps representative of the tetraploid state following S phase in the cell cycle, due to its interaction with citron-K kinase (CK); 2) RV infection induces apoptosis in cell culture, and 3) CK functional perturbations lead to tetraploidy, followed by apoptosis, in specific cell types. CONCLUSIONS: Based on several similarities between known RV-associated fetal and cellular manifestations and CK deficiency-associated phenotypes, it is reasonable to postulate that P90-CK interaction in RV-infected cells interferes with CK function and induces cell-cycle arrest following S phase in a subpopulation, perhaps representative of tetraploid stage, which could lead to subsequent apoptosis in RV infection. Taking all these observations to the fetal organogenesis level, it is plausible that P90-CK interaction could perhaps be one of the initial steps in RV infection-induced apoptosis-associated fetal birth defects in utero.lld:pubmed
pubmed-article:15259032pubmed:languageenglld:pubmed
pubmed-article:15259032pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15259032pubmed:citationSubsetIMlld:pubmed
pubmed-article:15259032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15259032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15259032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15259032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15259032pubmed:statusMEDLINElld:pubmed
pubmed-article:15259032pubmed:monthJullld:pubmed
pubmed-article:15259032pubmed:issn1542-0752lld:pubmed
pubmed-article:15259032pubmed:authorpubmed-author:KulkarniSSlld:pubmed
pubmed-article:15259032pubmed:authorpubmed-author:AtreyaC DCDlld:pubmed
pubmed-article:15259032pubmed:authorpubmed-author:MohanK V KKVlld:pubmed
pubmed-article:15259032pubmed:issnTypePrintlld:pubmed
pubmed-article:15259032pubmed:volume70lld:pubmed
pubmed-article:15259032pubmed:ownerNLMlld:pubmed
pubmed-article:15259032pubmed:authorsCompleteYlld:pubmed
pubmed-article:15259032pubmed:pagination431-7lld:pubmed
pubmed-article:15259032pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:meshHeadingpubmed-meshheading:15259032...lld:pubmed
pubmed-article:15259032pubmed:year2004lld:pubmed
pubmed-article:15259032pubmed:articleTitleRubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level.lld:pubmed
pubmed-article:15259032pubmed:affiliationSection of Viral Pathogenesis and Vaccine Adverse Reactions, Division of Viral Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, USA. atreya@cber.fda.govlld:pubmed
pubmed-article:15259032pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15259032pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15259032pubmed:publicationTypeReviewlld:pubmed